The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.
about
Importance of disulphide bonds for vaccinia virus L1R protein function.Poxvirus cell entry: how many proteins does it take?Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansStructural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 proteinThe Structure of the Poxvirus A33 Protein Reveals a Dimer of Unique C-Type Lectin-Like DomainsStructural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 ProteinA protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.Kinetics and intracellular location of intramolecular disulfide bond formation mediated by the cytoplasmic redox system encoded by vaccinia virus.Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challengeThe membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell componentsThe myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entryThe structure of G4, the poxvirus disulfide oxidoreductase essential for virus maturation and infectivity.Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.Development and evaluation of single domain antibodies for vaccinia and the L1 antigenDevelopment of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses - Target Selection and Optimized ScreeningAdsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challengeRedundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.Immunity and immunological memory following smallpox vaccination.Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.Vaccinia virus l1 protein is required for cell entry and membrane fusion.Poxvirus proteomics and virus-host protein interactions.Membrane fusion during poxvirus entry.Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins.Protein Primary Structure of the Vaccinia Virion at Increased ResolutionElectron transfer reactivity of the Arabidopsis thaliana sulfhydryl oxidase AtErv1.Chemistry and Enzymology of Disulfide Cross-Linking in Proteins.The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex
P2860
Q24814076-58F70A64-6040-4C8C-9AAC-6A0AFD6B4CC0Q27002455-6F5F77E7-7D22-41C4-A7F5-B775B2280AABQ27488704-08189133-03DD-435F-8FCE-33A2616D0542Q27647102-4A319B2E-717E-4553-AB7E-01585D133EFDQ27658759-7DD0F051-E5F2-4DAC-A6A0-F6A7D2967EB6Q27679281-7347AC9F-B444-43F4-A0A1-5B53D92FC470Q27684713-558E6A52-EAF1-4ED1-881F-C24442A870BCQ30445071-4F71E4F6-70E1-4E3C-A6AB-3E1EF5CD0592Q33664851-8B1DF085-C029-4C29-BEA6-DF6E7FD4E6D6Q34092845-40216958-9C26-4DEF-A725-B70A35039C02Q34109783-FD17EC56-4CC4-4E03-8F78-C7AC2E5110F9Q34259469-8D5A5936-EF7A-4AF5-B424-2ABE3EB74580Q35023719-B01848A1-1F63-440B-826D-E36E8780FF55Q35101363-74498038-DC6B-4F31-B46C-DC70872C41E9Q35248202-56B2BD38-9BD5-4673-A347-0923AF53A5F9Q35941208-1C5517C2-3EFE-49D2-BF41-92523316F173Q36487366-88D5D0AC-E803-4710-9DD7-58BDCE30059FQ36498147-186F212A-8B11-4DA4-BA6B-1E61BFEE4834Q36529039-12E0270C-E3B9-4386-8EC7-5594F381D07EQ36825059-EF5BB187-9C7D-40F4-9856-C8FD4CF2B999Q36845650-9F54A54B-BC46-4FD8-A4C2-24F7EE8217FEQ36845831-F7F885BC-7B41-4B3D-88DC-BE3446881BD6Q37640977-43B053CC-8FEE-4573-8F15-3B31CE7FD2AFQ38899115-8A679DBC-3913-4FB0-9E4F-D9FAB50B5623Q39167579-94E87635-676B-4552-9FA0-0DCB2ECDA8C6Q40608542-D7DE03E1-5E16-4546-8985-8FE04B910D1AQ46239602-8F0EC127-B9A5-42B2-909D-288F60B04D01Q48139731-5C9EC1D0-3A7C-45B8-83F7-D0F6D12F0386Q59127072-1B6117B4-42BB-4B1C-84CC-DBEE9A022E5C
P2860
The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@ast
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@en
type
label
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@ast
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@en
prefLabel
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@ast
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@en
P2093
P2860
P356
P1476
The 1.51-Angstrom structure of ...... otent neutralizing antibodies.
@en
P2093
Christiana Fogg
David N Garboczi
Hua-Poo Su
Scott C Garman
Timothy J Allison
P2860
P304
P356
10.1073/PNAS.0501103102
P407
P50
P577
2005-03-10T00:00:00Z